Related Experiment Video
Updated: Feb 1, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
Clinical value of enzyme immunoassay that detects rubella-specific immunoglobulin M immediately after disease onset
Takako Kurata1, Kiyoko Uchino2, Chiemi Hotta3
1Osaka Institute of Public Health, 1-3-69, Nakamichi, Higashinari-ku, Osaka, 537-0025, Japan.
Abstract:
A total of 300 patients with nucleic acid test-confirmed rubella, mostly adults, were investigated to determine the clinical value of a rubella-specific IgM test using an EIA kit. IgM titers increased after rash onset, the median IgM titer being significantly higher 3 days post-onset than on previous days (P < 0.0001). Similarly, the IgM-positive rate at 3 days post-onset (61.5%) was significantly higher than on previous days (P < 0.0001). This IgM test against rubella at 3 days or more post-disease onset provides the clinically relevant information.
Insights
The rubella-specific IgM test is clinically valuable for diagnosing rubella in adults. IgM antibody levels and positive rates significantly increase three days after rash onset, aiding in timely diagnosis.
Area of Science:
- Virology
- Immunology
- Diagnostic Medicine
Background:
- Rubella, a viral infection, poses risks, especially to adults.
- Accurate and timely diagnosis is crucial for managing rubella outbreaks and patient care.
Purpose of the Study:
- To evaluate the clinical utility of a rubella-specific IgM enzyme immunoassay (EIA) test.
- To determine the optimal timing for IgM testing post-rubella symptom onset.
Main Methods:
- Investigated 300 adult patients with confirmed rubella via nucleic acid testing.
- Utilized a rubella-specific IgM enzyme immunoassay (EIA) kit.
- Analyzed IgM titers and positive rates at various time points after rash onset.
Main Results:
- Median IgM titers significantly increased by 3 days post-rash onset (P < 0.0001).
- The IgM-positive rate reached 61.5% at 3 days post-onset, significantly higher than earlier time points (P < 0.0001).
Conclusions:
- The rubella-specific IgM EIA test provides clinically relevant diagnostic information.
- Testing for rubella IgM antibodies at 3 days or more after disease onset is recommended for accurate diagnosis.
Related Concept Videos
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Chronic Kidney Disease II: Clinical Manifestations
Enzyme Kinetics
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Coronary Artery Disease III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinically Relevant Drug Product Specifications: Methods of Establishment

